In ERα positive endometrial and breast cancer cell lines, E2 increased PD-L1 protein expression in both a dose- and time-dependent manner via the phosphoinositide 3 kinase (PI3K/Akt) pathway and post-transcriptional PD-L1 mRNA stabilization (170). Here, ESR1 is linked to breast carcinoma.